| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.3.3.215 |
| P698 | PubMed publication ID | 6847521 |
| P2093 | author name string | Hessler JR | |
| Chisolm GM | |||
| Morel DW | |||
| Lewis LJ | |||
| P433 | issue | 3 | |
| P304 | page(s) | 215-222 | |
| P577 | publication date | 1983-05-01 | |
| P1433 | published in | Arteriosclerosis (Dallas, Tex.) | Q27709176 |
| P1476 | title | Lipoprotein oxidation and lipoprotein-induced cytotoxicity | |
| P478 | volume | 3 |
| Q35916215 | 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein |
| Q28485243 | A quantitative proteomic profile of the Nrf2-mediated antioxidant response of macrophages to oxidized LDL determined by multiplexed selected reaction monitoring |
| Q33836010 | A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein |
| Q35588124 | AGING OF THE SUBVENTRICULAR ZONE NEURAL STEM CELL NICHE. |
| Q42756254 | Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy |
| Q35818180 | Activation of human peripheral blood monocytes by lipoproteins. |
| Q34133240 | Aggregation and fusion of low-density lipoproteins in vivo and in vitro |
| Q44725604 | Alpha-tocopherol preserves endothelial cell migration in the presence of cell-oxidized low-density lipoprotein by inhibiting changes in cell membrane fluidity |
| Q37125684 | Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors |
| Q37742366 | Antioxidants and atherosclerosis: a current assessment. |
| Q40928840 | Antioxidants in cardiovascular disease: randomized trials |
| Q21342954 | Apocynin: molecular aptitudes |
| Q41446069 | Atheroarteritis: a combined immunological and lipid imbalance. |
| Q28212769 | Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime |
| Q39365197 | Atherosclerosis Induced by Chlamydophila pneumoniae: A Controversial Theory |
| Q41291878 | Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. |
| Q36540637 | Biochemical properties of vascular endothelial cells |
| Q44755589 | Cellular damage in mouse peritoneal macrophages exposed to cholesteryl linoleate |
| Q40821396 | Cellular mechanisms of lipid injury in the glomerulus |
| Q73451637 | Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein |
| Q32062976 | Characterization of peroxynitrite-oxidized low density lipoprotein binding to human CD36. |
| Q48319815 | Cholesterol and oxygenated cholesterol concentrations are markedly elevated in peripheral tissue but not in brain from mice with the Niemann-Pick type C phenotype |
| Q46455968 | Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis |
| Q37201967 | Cytotoxicity of Remnants of Triglyceride-Rich Lipoproteins: An Atherogenic Insult? |
| Q71807006 | Detection of short-chain α-hydroxyaldehydic compounds as pentafluorbenzyloxime derivatives in bovine liver |
| Q41386397 | Diet and heart disease. The role of fat, alcohol, and antioxidants |
| Q33834133 | Dietary antioxidants and cardiovascular disease |
| Q41054029 | Differential ability of cells to promote oxidation of low density lipoproteins in vitro |
| Q35125378 | Does Vitamin E Supplementation Prevent Cardiovascular Events? |
| Q41432893 | Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions? |
| Q46476626 | Dose response of fish oil versus safflower oil on graft arteriosclerosis in rabbit heterotopic cardiac allografts |
| Q40304125 | Dual Ca2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytes |
| Q41898952 | Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation |
| Q50799482 | Effects of cholesterol oxidase on cultured vascular smooth muscle cells |
| Q64889953 | Effects of dietary vitamin C and E supplementation on the copper mediated oxidation of HDL and on HDL mediated cholesterol efflux. |
| Q36508434 | Effects of exercise on the development of atherosclerosis in apolipoprotein E-deficient mice. |
| Q85569120 | Effects of fruit juices of Citrus sinensis L. and Citrus limon L. on experimental hypercholesterolemia in the rat |
| Q61566495 | Effects of β-carotene and α-tocopherol on the levels of tissue cholesterol and triglyceride in hypercholesterolemic rabbits |
| Q78749386 | Exposure to oxidized low-density lipoprotein reduces activable Ras protein in vascular endothelial cells |
| Q37526630 | Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein |
| Q48103315 | Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages |
| Q35811780 | Focal toxicity of oxysterols in vascular smooth muscle cell culture. A model of the atherosclerotic core region |
| Q34201185 | Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes |
| Q39634435 | Free radicals in medicine. II. Involvement in human disease |
| Q47925617 | Functional activity of blood polymorphonuclear leukocytes as an oxidative stress biomarker in human subjects |
| Q74452472 | Glycation of high-density lipoprotein does not increase its susceptibility to oxidation or diminish its cholesterol efflux capacity |
| Q41687447 | Glycation, oxidation, and lipoxidation in the development of diabetic complications |
| Q36052417 | Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis |
| Q71665385 | Growth requirements of endothelial cells in culture: variations in serum and amino acid concentrations |
| Q33535928 | Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts |
| Q41089057 | High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase |
| Q35641503 | Human monocytes are severely impaired in base and DNA double-strand break repair that renders them vulnerable to oxidative stress |
| Q49129166 | Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules |
| Q73103541 | Hypochlorite modified LDL are a stronger agonist for platelets than copper oxidized LDL |
| Q44512789 | Hypoglycaemic effect of water extracts of Aegle marmelos fruits in streptozotocin diabetic rats |
| Q68183783 | Identification of cholesterol-bound aldehydes in copper-oxidized low density lipoprotein |
| Q35764487 | In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals |
| Q42203761 | In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts |
| Q35773691 | Induction of apoptosis in endothelial cells treated with cholesterol oxides |
| Q44993897 | Ingestion of eicosapentaenoic acid-ethyl ester renders rabbit LDL less susceptible to Cu2(+)-catalyzed-oxidative modification |
| Q43950065 | Inhibition of human low density lipoprotein oxidation by active principles from spices |
| Q34620804 | Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture |
| Q53868487 | Iron status and risk of cardiovascular disease. |
| Q73256291 | Isolation, Characterization, and Functional Assessment of Oxidatively Modified Subfractions of Circulating Low-Density Lipoproteins |
| Q77682968 | Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases |
| Q36725904 | Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability |
| Q35364817 | Lipid peroxidation--a common pathogenetic mechanism? |
| Q37786785 | Lipids and thrombosis |
| Q45984995 | Lipofuscin and lipid oxidation in human coronary endothelium. |
| Q30820478 | Lipoprotein lipase, a key role in atherosclerosis? |
| Q39713469 | Lipoprotein oxidation and cytotoxicity: Effect of probucol on streptozotocin-treated rats |
| Q40582663 | Lipoproteins and the haemostatic system in atherothrombotic disorders |
| Q68275944 | Low superoxide scavenging activity associated with enhanced superoxide generation by monocytes from male hypertriglyceridemia with and without diabetes |
| Q74106117 | Lysophosphatidylcholine induces apoptotic and non-apoptotic death in vascular smooth muscle cells: in comparison with oxidized LDL |
| Q40815836 | Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products |
| Q77889077 | Major differences in oxysterol formation in human low density lipoproteins (LDLs) oxidized by *OH/O2*- free radicals or by copper |
| Q40904891 | Mechanism of dacron-activated monocytic cell oxidation of low density lipoprotein |
| Q40443396 | Mechanisms of free radical oxidation of unsaturated lipids |
| Q41873727 | Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells |
| Q35614606 | Modified low density lipoproteins suppress production of a platelet-derived growth factor-like protein by cultured endothelial cells |
| Q33834184 | Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins |
| Q100568733 | NET-associated citrullinated histones promote LDL aggregation and foam cell formation in vitro |
| Q53623040 | Nobiletin, a citrus flavonoid, suppresses phorbol ester-induced expression of multiple scavenger receptor genes in THP-1 human monocytic cells. |
| Q35711553 | Non-insulin dependent diabetes and ischaemic heart disease |
| Q35006536 | Novel insights into the molecular mechanisms of the antiatherosclerotic properties of antioxidants: the alternatives to radical scavenging |
| Q36365606 | On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety |
| Q74182936 | Oxidation and atherosclerosis |
| Q74469913 | Oxidative modification of HDL3 in vitro and its effect on PLTP-mediated phospholipid transfer |
| Q67955363 | Oxidative modification of low density lipoprotein (LDL) by activated human monocytes and the cell lines U937 and HL60 |
| Q42274447 | Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta |
| Q42483490 | Oxidized LDL from subjects with different dietary habits modifies atherogenic processes in endothelial and smooth muscle cells |
| Q37096432 | Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes? |
| Q42591234 | Oxidized Low-density Lipoprotein- and Lysophosphatidylcholine-induced Ca Mobilization in Human Endothelial Cells |
| Q78306584 | Oxidized lipid protects against sepsis |
| Q39766988 | Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages |
| Q36383066 | Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro |
| Q34255186 | Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery |
| Q72426803 | Oxidized low-density lipoprotein is cytotoxic to human monocyte-macrophages: protection with lipophilic antioxidants |
| Q35047186 | Oxidized low-density lipoprotein-induced apoptosis |
| Q67794899 | Oxygen radicals alter LDL permeability and uptake by an endothelial-smooth muscle cell bilayer |
| Q77910747 | Oxysterols and atherosclerosis |
| Q61637521 | Oxysterols from oxidized LDL are cytotoxic but fail to induce hsp70 expression in endothelial cells |
| Q77725015 | Plasma and low-density lipoprotein lipid peroxidation in cyclosporine A-treated children after liver transplant |
| Q73715925 | Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia |
| Q42068195 | Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper |
| Q50997118 | Production of superoxide anion by polymorphonuclear leukocytes from diabetic patients with or without diabetic retinopathy. |
| Q41940881 | Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells |
| Q33901989 | Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase |
| Q43806002 | Quantity versus quality of LDL cholesterol in patients with familial hypercholesterolemia--which is more important? |
| Q34006254 | Regulation of cell growth by oxidized LDL. |
| Q36890268 | Role of lipoprotein peroxidation in the pathogenesis of atherosclerosis |
| Q37356330 | Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein |
| Q71662882 | Serum factor from diabetic patients with or without retinopathy stimulates superoxide anion production by normal polymorphonuclear leukocytes |
| Q78564759 | Smooth muscle cell proliferation induced by oxidized LDL-borne lysophosphatidylcholine. Evidence for FGF-2 release from cells not extracellular matrix |
| Q35586059 | Stimulated arachidonate metabolism during foam cell transformation of mouse peritoneal macrophages with oxidized low density lipoprotein |
| Q41449793 | Stress proteins and atherosclerosis |
| Q37326175 | The LDL modification hypothesis of atherogenesis: an update |
| Q42201820 | The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes |
| Q71688339 | The effect of peroxides on the vascular endothelium of isolated pig aorta in vitro |
| Q26824356 | The human paraoxonase gene cluster as a target in the treatment of atherosclerosis |
| Q34006328 | The oxidative modification hypothesis of atherogenesis: an overview |
| Q42795258 | The oxidative modification of low-density lipoproteins by macrophages |
| Q67805609 | Tocopherol contents of lipoproteins from frozen plasma separated by affinity chromatography |
| Q41643412 | UV-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. 4. Calcium is involved in the cytotoxicity of UV-treated LDL on lymphoid cell lines |
| Q44917911 | Ultrastructural study of malonaldehyde-induced arterial lesions in chickens. |
| Q51633218 | Uptake of irradiated human low density lipoprotein by cultured Chinese hamster V79 cells. |
| Q33828621 | Vitamin E and heart disease: basic science to clinical intervention trials |
| Q70794029 | [Cell damage as reason for the formation of unsaturated fatty acid hydroperoxides] |
| Q54186121 | alpha-Tocopherol, ascorbic acid, and rutin inhibit synergistically the copper-promoted LDL oxidation and the cytotoxicity of oxidized LDL to cultured endothelial cells. |
| Q86757284 | oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4 |
Search more.